Gan & Lee

Gan & Lee, founded 1998 in Beijing, is a leading Chinese manufacturer of insulin analog APIs and injection products—including Basalin, Prandilin, Rapilin—and complementary insulin delivery devices, positioning it as a key supplier in the diabetes therapeutics market.

Headquarters: China (CHN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 5,245
HQ: Beijing

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
603087	Gan & Lee Rg-Class A Cap: 43.5B \| P/E: 46.4	EQUITY	SHH	CNY	CNE100003ZH1	Active	📈